DFDA

Contingency Management

Treatment for Amphetamine Use Disorders

Typical Dosage: 2-3 urine drug screens per week, escalating rewards

Effectiveness
85%
Safety Score
95%
Clinical Trials
1
Participants
5.2K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
2-3 urine drug screens per week, escalating rewards
Time to Effect
1-2 weeks
Treatment Duration
12-24 weeks
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$750
Side Effect Mgmt:$0
Total Annual:$4,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$35,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$7,308
Cost per Remission
$13,571
Contingency Management Outcomes

for Amphetamine Use Disorders

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+65%
Remission Rate
+35%
Common Side Effects
Ethical concerns regarding external rewards
+8%

Sources:

nih.gov
jhsph.edu
societyforpsychotherapy.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov